Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Gemini Pharmaceuticals, Inc.
FDA Inspection
•Gemini Pharmaceuticals, Inc.•May 15, 2026

Gemini Pharmaceuticals, Inc. – FDA Inspection, May 15, 2026

Record Details

This FDA Inspection record concerns Gemini Pharmaceuticals, Inc., with an inspection on May 15, 2026, issued by the New York District Office, covering foods & cosmetics.

Company
Gemini Pharmaceuticals, Inc.
Inspection Date
May 15, 2026
Product Type
Foods & Cosmetics
Office
New York District Office
People
  • Jung K. Kim (Issuing Officer)
  • Meredith P. Soehl (FDA Associated Person)
View Company Profile

ID · 3c2276f9-a20a-4803-a2e7-9277b1bf2a74

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1317530
FDA center
Foods & Cosmetics
Project area
Food Composition, Standards, Labeling and Econ
Outcome
Form 483 issued

FDA Citations

7
  1. 21 CFR 111.260Batch record - required information
  2. 21 CFR 111.315(b)Sampling plans; establish, follow
  3. 21 CFR 111.315(d)Standard reference materials; criteria for selecting
  4. 21 CFR 111.70(b)Specifications - components
  5. 21 CFR 111.70(e)Specifications - finished dietary supplement
  6. 21 CFR 111.75(a)(2)(ii)(A)Component - qualify supplier
  7. 21 CFR 111.75(d)(1)Documentation specifications met; exempted, periodic testing

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Gemini Pharmaceuticals, Inc.

9
DateClassificationOfficeProject area
July 26, 2022VAICenter for Food Safety and Applied NutritionFood Composition, Standards, Labeling and Econ
August 23, 2018NAICenter for Food Safety and Applied NutritionFood Composition, Standards, Labeling and Econ
February 16, 2018VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
June 30, 2015VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 8, 2013NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 9 other inspections on the company page
Other documents for Gemini Pharmaceuticals, Inc.
  • FDA Inspection 1175407 - 2022-07-26
  • FDA Inspection 1064447 - 2018-08-23
  • FDA Inspection 1041525 - 2018-02-16
  • FDA Inspection 936886 - 2015-06-30
  • FDA Inspection 856101 - 2013-11-08

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Gemini Pharmaceuticals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.